Celltrion chairman\
Scope
Date
~
-
Executive reshuffles
LG Energy's new CEO aims to focus on qualitative growth
LG Energy Solution Ltd., the world’s second-largest electric vehicle battery maker, is set to focus on qualitative growth by securing leading ...
Dec 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Remsima SC to be launched in US in 2024
Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...
Nov 30, 2023 (Gmt+09:00)
-
Executive reshuffles
Samsung sets up future business planning unit, keeps co-CEO system
Samsung Electronics Co., the world’s largest maker of memory chips and smartphones, is creating a new division tasked with working out future ...
Nov 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Asset management
Fed rate likely to be 2-4% over next decade: Oaktree's Howard Marks
Investors are experiencing the third “sea change,” facing the Federal Reserve’s rate hikes and its impact on economies and busines...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima to Brazil gov’t in three-year row
South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...
Nov 10, 2023 (Gmt+09:00)
-
Korean startups
Goldman Sachs lists Moloco CEO among exceptional entrepreneurs
Moloco Inc., a Silicon Valley-based ad-tech solution startup, said Wednesday that its co-founder and Chief Executive Ikkjin Ahn was named one of the...
Nov 09, 2023 (Gmt+09:00)
-
Earnings
Celltrion enjoys record earnings on healthy biosimilar biz
South Korean pharmaceutical giant Celltrion Inc. logged record quarterly earnings on the strong performance of its key biosimilar products while exp...
Nov 07, 2023 (Gmt+09:00)
-
Leadership & Management
Mirae Asset promotes Indian unit head to vice chairman
Mirae Asset Financial Group, South Korea’s leading financial conglomerate, on Monday promoted Swarup Mohanty, the head of its Indian asset man...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s approved merger removes hurdle to three-way combination
South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wi...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Remsima SC
South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...
Oct 23, 2023 (Gmt+09:00)
-
Leadership & Management
SK Group needs agility to survive disruptions: chairman
South Korea's No. 2 conglomerate SK Group needs agile responses to rapidly changing business circumstances amid global geopolitical crises, C...
Oct 20, 2023 (Gmt+09:00)
-
Corporate strategy
Late Samsung chairman Lee's New Management back in spotlight
As the leader of Samsung Group for three decades, the late group Chairman Lee Kun-hee brought fundamental changes to the conglomerate under his &ldq...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare wins Remsima order in France, Italy
South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for ho...
Oct 18, 2023 (Gmt+09:00)
-
Steel
POSCO Group chief: steel desperately needs corporate solidarity
South Korea’s POSCO Group on Tuesday said its Chairman Choi Jeong-woo presided over the regular meeting of the World Steel Association on Su...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare to supply Yuflyma to US pharmacy chain
South Korea's Celltrion Healthcare Co. has inked a deal with the US specialty pharmacy chain CarePartners Pharmacy to supply its autoimmune disease ...
Oct 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Proxy adviser ISS backs drug giant Celltrion's merger plan
South Korean drug giant Celltrion Group has received a positive recommendation from Institutional Shareholder Services (ISS), a global leading proxy...
Oct 06, 2023 (Gmt+09:00)
-
Samsung Group
Samsung Chair Lee tours Middle East, ‘treasure trove’ of future growth
Jay Y. Lee, executive chairman of Samsung Electronics Co., has made his second visit in 10 months to the operations of South Korea’s most powe...
Oct 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Pharm gets GMP certification from Japan
Celltrion Pharm Inc. announced on Wednesday that its pre-filled syringe (PFS) production facility in Cheongju, North Chungcheong Province has obtain...
Sep 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets sales approval for Yuflyma in Japan
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it has secured approval from the Japanese Ministry of Health, Labou...
Sep 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion signs largest-ever quarterly deal with global sales affiliate
Celltrion Inc., a South Korean biopharmaceutical giant, said Monday it will provide biosimilars worth 423.6 billion won ($323.6 million), its larges...
Sep 25, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Dongwon founder vows to acquire Korea’s top container line HMM
Dongwon Group, South Korea’s leading seafood and logistics conglomerate, has vowed to acquire HMM Co., the country’s top container ship ...
Sep 19, 2023 (Gmt+09:00)
-
Business & Politics
Hyundai eyes Saudi EV plant as Korea bets on Middle East boom
Hyundai Motor Co. is set to build an electric vehicle assembly plant in Saudi Arabia as South Korean companies are increasingly tapping growth oppor...
Sep 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare to supply Yuflyma to five regional gov’ts in Italy
South Korea's Celltrion Healthcare Co. announced on Monday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatm...
Sep 18, 2023 (Gmt+09:00)
-
Corporate strategy
SK Chairman Chey vows to turn Ulsan into green energy, AI hub
Chey Tae-won, chairman of South Korea’s second-largest conglomerate SK Group, has vowed to turn the industrial city of Ulsan, where SK’s...
Sep 15, 2023 (Gmt+09:00)
-
KOREA Investment Week
Celltrion builds clinical data bank for new biosimilars
The use of data and computing is a new paradigm in the biopharmaceutical industry, reducing the new drug development time and cost, Celltrion Inc. C...
Sep 12, 2023 (Gmt+09:00)
-
Banking & Finance
KB Financial Vice Chairman Yang named sole chairman candidate
KB Financial Group Inc. has chosen Yang Jong-hee, its vice chairman, as the sole candidate for its next chief in charge of South Korea’s leadi...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand new plant for drug products
South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday that it plans to enlarge its finished pharmaceuticals manufacturing facility...
Sep 05, 2023 (Gmt+09:00)
-
Electronics
Corning stepping stone for Samsung's global leap: Chairman Lee
Their relationship dates back to 1973 when Samsung founder Lee Byung-chull and Amory Houghton Jr., then-chairman of Corning Inc., met to discuss a b...
Sep 01, 2023 (Gmt+09:00)
-
Leadership & Management
SK Group commemorates chairman's 25th year since inauguration
SK Group, South Korea’s No. 2 conglomerate, will commemorate the 25th anniversary of Chey Tae-won’s inauguration as chairman on Sept. 1....
Aug 31, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand